查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1818424

药物滥用即时检测市场报告：2031 年趋势、预测与竞争分析

Point-of-Care Testing (POCT) for Substance Abuse Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球药物滥用即时检测 (POCT) 市场预计将在医院、诊断中心、康復中心、职场检测机构以及家用检测套组市场中迎来机会。预计2025年至2031年期间，全球药物滥用即时检测 (POCT) 市场的复合年增长率将达到9.0%。该市场的主要驱动力是对预防性医疗保健措施的日益重视，以及便携式和用户友好型检测设备的不断发展。

  • 根据 Lucintel 的预测，按类型分類的胶体金市场预计在预测期内将出现高速成长。
  • 从应用来看，医院预计将实现最高的成长。
  • 按地区划分，预计亚太地区将在预测期内实现最高成长。

药物滥用即时检测市场的新趋势

由于技术创新和市场需求的变化，药物滥用POCT市场正在快速发展。随着全球打击药物滥用的力度加大，对更快、更准确、更具成本效益的检测方法的需求日益增长。以下是塑造市场的五大关键趋势：

  • 多重检测设备：多重检测设备能够在单一样本中检测多种物质，在药物滥用即时检测 (POCT) 市场中日益普及。这些设备使医疗保健提供者、雇主和执法机构能够同时检测多种药物，从而提高检测效率。它们有助于减少单独进行多项检测的成本和时间，并提高结果的准确性。随着多重检测设备日益复杂，预计它们将成为各领域快速药物检测的首选解决方案。
  • 与数位健康平台整合：药物滥用 POCT 设备正越来越多地与数位健康平台集成，从而实现即时数据收集、监控和彙报。这些平台允许医疗保健提供者和雇主远端追踪检测结果，并监控个人的长期用药情况。这种整合对于成瘾康復计画尤其有益，因为它有助于持续监控，并允许制定更个人化的治疗方案。它还能改善患者与医疗保健提供者之间的沟通，从而提高药物滥用管理计画的整体有效性。
  • 家用检测套组：家用检测套组是药物滥用即时检测 (POCT) 市场的新兴趋势，特别适用于监测康復患者和治疗依从性。这些套件为患者提供隐私、便利性和易用性，使他们能够在舒适的家中进行药物检测。随着药物滥用监测成为长期治疗方案的重要组成部分，家用检测解决方案对于难以获得医疗服务的患者而言是极具价值的工具。这些套件也为患者管理復原过程提供了更大的灵活性和自主性。
  • 非侵入性检测：向唾液、汗液和呼吸分析等非侵入性检测方法的转变是药物滥用POCT市场的关键趋势。与传统的尿液检查和血液检测相比，这些检测具有许多优势，包括更舒适、更少的隐私顾虑以及更快的检测结果。非侵入性检测在需要频繁随机检测的职场、学校和执法部门尤其有用。随着技术的进步，非侵入性检测预计将变得更加可靠，并被广泛接受作为常规药物滥用监测的一部分。
  • 行动和可携式检测解决方案：行动和可携式检测解决方案正在改变即时检测 (POCT) 市场，使药物检测更加便利灵活。这些可随处存取的设备在医疗服务有限的偏远地区和服务欠缺地区尤其有用。行动检测设备还能即时快速地提供结果，为执法部门和职场的检测提供便利。更小巧、更紧凑、更易于使用和携带的设备的发展正在扩大即时检测 (POCT) 的覆盖范围，使药物滥用监测随时随地进行。

多重检测设备、数位健康整合、家用检测套组、非侵入性检测以及行动解决方案等新兴趋势正在改变药物滥用即时诊断 (POCT) 市场。这些趋势提高了检测的可及性、效率和准确性，从而能够更好地管理药物滥用并监测康復情况。随着这些趋势的不断发展，它们将塑造药物检测的未来，并改善全球个人和社区的治疗效果。

药物滥用 POCT 市场的最新趋势

药物滥用 POCT 市场的最新趋势受到技术进步、药物滥用加剧以及对更高效检测解决方案的需求的推动。这些发展正在改变医疗保健、职场和执法部门的药物检测模式。以下是重塑市场的五个近期关键趋势。

  • 快速多重药物检测简介：快速多重药物检测是即时检验 (POCT) 市场的重大发展。这些检测可以在单一样本中检测多种物质，从而为医疗保健提供者、雇主和执法部门提供更快、更有效率的结果。多重药物检测省去了对每种物质进行单独检测所需的时间和成本，有助于简化各种环境下的药物检测流程。这项发展对于专注于监测多种药物使用问题患者的专案以及改善职场安全至关重要。
  • 即时监控的数位整合技术进步：数位技术的最新进展使得即时检测 (POCT) 设备与数位平台的整合更加便捷，从而实现即时监控和报告。医疗保健提供者和雇主现在可以即时追踪药物检测结果，确保更快地介入并更好地管理药物滥用案例。这项进展对于成瘾治疗计画尤其有益，因为持续监控药物使用至关重要。此外，它还能确保更准确、更及时的决策，进而增强职场药物检测项目的效果。
  • 非侵入性检测技术的发展：唾液、汗液和呼吸分析等非侵入性检测方法在即时检测（POC​​T）市场中取得了长足进步。这些方法创伤小、操作便捷，非常适合在学校、职场和医疗保健场所使用。执法机构也正在进一步扩展非侵入性检测技术，用于街头毒品检测。随着这些技术的进步，它们预计将变得更加可靠，并获得更广泛的认可，尤其是在需要频繁或随机检测的环境中。
  • 提升检测设备的准确性和灵敏度：药物滥用即时检测 (POCT) 设备的最新进展致力于提高检测的准确性和灵敏度。这包括开发更精确的方法来检测体内微量物质，例如Fentanyl，芬太尼是鸦片类药物氾滥的重要关注点。透过提高检测可靠性，这些创新有助于减少假阳性和假阴性，确保检测结果准确可靠。提高准确性对于成瘾治疗、职场药物检测和执法监控至关重要。
  • 监管部门支持加快检测设备核准：监管机构越来越多地支持加快药物滥用即时检测设备的核准，从而加快新型和改进型检测解决方案的上市速度。例如，能够同时检测多种药物的设备正在获得更快的监管核准，确保医疗保健提供者、雇主和执法机构拥有应对日益严重的药物滥用问题所需的工具。这些监管变化正在推动即时检测 (POCT) 市场的创新。

药物滥用即时检测 (POCT) 市场的最新趋势，包括多重药物检测、数位化整合、非侵入性检测、更高的准确性以及监管支持，正在彻底改变药物检测格局。这些进步提高了检测的速度、准确性和可近性，对于在医疗保健、职场和执法环境中更好地管理药物滥用至关重要。随着这些技术的不断发展，它们将在打击药物滥用方面发挥关键作用。

目录

第一章执行摘要

第二章 市场概况

  • 背景和分类
  • 供应链

第三章：市场趋势及预测分析

  • 宏观经济趋势与预测
  • 产业驱动力与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

4. 全球药物滥用即时检测市场（按类型）

  • 概述
  • 按类型进行吸引力分析
  • 胶体金基底：趋势与预测（2019-2031）
  • 基于萤光层析法的趋势与预测（2019-2031）

5. 全球药物滥用即时检测市场（按应用）

  • 概述
  • 按用途进行吸引力分析
  • 医院：趋势与预测（2019-2031）
  • 诊断中心：趋势与预测（2019-2031）
  • 復健中心：趋势与预测（2019-2031）
  • 职场测试实验室：趋势与预测（2019-2031）
  • 家庭检测套组：趋势与预测（2019-2031）

第六章 区域分析

  • 概述
  • 按地区划分：全球药物滥用即时检测市场

7. 北美药物滥用即时检测市场

  • 概述
  • 北美药物滥用即时检测市场（按类型）
  • 北美药物滥用即时检测市场（按应用）
  • 美国药物滥用即时检测市场
  • 墨西哥药物滥用即时检测市场
  • 加拿大药物滥用即时检测市场

8. 欧洲药物滥用即时检测市场

  • 概述
  • 欧洲药物滥用即时检测市场（按类型）
  • 欧洲药物滥用即时检测市场（按应用）
  • 德国药物滥用即时检测市场
  • 法国药物滥用即时检测市场
  • 西班牙药物滥用即时检测市场
  • 义大利药物滥用即时检测市场
  • 英国药物滥用即时检测市场

9. 亚太地区药物滥用即时检测市场

  • 概述
  • 亚太地区药物滥用即时检测市场（按类型）
  • 亚太地区药物滥用即时检测市场（按应用）
  • 日本药物滥用POCT市场
  • 印度药物滥用即时检测市场
  • 中国药物滥用即时检测市场
  • 韩国药物滥用POCT市场
  • 印尼药物滥用即时检测市场

10. 其他地区药物滥用 POCT 市场

  • 概述
  • 世界其他地区药物滥用即时检测市场（按类型）
  • 世界其他地区药物滥用即时检测市场（按应用）
  • 中东地区药物滥用即时检测市场
  • 南美洲区域药物滥用即时检测市场
  • 非洲区域药物滥用即时检测市场

第11章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市占率分析

第十二章：机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按类型分類的成长机会
    • 按应用分類的成长机会
  • 全球药物滥用即时检测市场的新趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 合併、收购、协议、合作和合资企业

第十三章 价值链主要企业的公司简介

  • 竞争分析
  • Roche
  • Danaher
  • Abbott
  • Siemens
  • Beijing Hotgen BIoTech
  • Hangzhou BIoTest BIoTech Co.
  • Assure Tech
  • Orient Gene
  • Thermo Fisher

第十四章 附录

  • 图表目录
  • 表格一览
  • 调查方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于我们
  • 联络处

The future of the global point-of-care testing (POCT) for substance abuse market looks promising with opportunities in the hospital, diagnostic center, rehabilitation centers, workplace testing facilities, and home testing kits markets. The global point-of-care testing (POCT) for substance abuse market is expected to grow with a CAGR of 9.0% from 2025 to 2031. The major drivers for this market are the rising focus on preventive healthcare measures and the increasing development of portable and user-friendly testing devices.

  • Lucintel forecasts that, within the type category, based on colloidal gold is expected to witness higher growth over the forecast period.
  • Within the application category, the hospital is expected to witness the highest growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Point-of-Care Testing (POCT) for Substance Abuse Market

The Point-of-Care Testing (POCT) for substance abuse market is evolving rapidly, driven by technological innovations and changing market needs. The demand for faster, more accurate, and cost-effective testing methods is growing as the global fight against substance abuse intensifies. Here are five key trends reshaping the market.

  • Multiplex Testing Devices: Multiplex testing devices that can detect multiple substances in a single sample are gaining popularity in the POCT market for substance abuse. These devices allow healthcare providers, employers, and law enforcement to test for a range of drugs simultaneously, making testing more efficient. They help reduce the cost and time associated with performing multiple separate tests and improve the accuracy of results. As multiplex devices become more sophisticated, they are expected to become the preferred solution for rapid drug testing across various sectors.
  • Integration with Digital Health Platforms: POCT devices for substance abuse are increasingly being integrated with digital health platforms, enabling real-time data collection, monitoring, and reporting. These platforms allow healthcare providers and employers to track test results remotely and monitor individuals' substance use over time. This integration is particularly beneficial for addiction recovery programs, as it facilitates continuous monitoring and allows for more personalized treatment plans. It also improves communication between patients and healthcare providers, enhancing the overall effectiveness of drug abuse management programs.
  • At-Home Testing Kits: At-home testing kits are becoming a growing trend in the POCT market for substance abuse, particularly for individuals undergoing rehabilitation or monitoring treatment adherence. These kits provide privacy, convenience, and ease of use for patients, allowing them to test for drugs in the comfort of their homes. As substance abuse monitoring becomes a more integral part of long-term treatment programs, at-home testing solutions offer a valuable tool for individuals who may not have easy access to medical facilities. These kits also offer more flexibility and autonomy for patients managing their recovery process.
  • Non-Invasive Testing Methods: The shift towards non-invasive testing methods such as saliva, sweat, and breath analysis is an important trend in the POCT market for substance abuse. These methods offer several advantages over traditional urine and blood testing, including increased comfort, reduced privacy concerns, and faster results. Non-invasive testing is particularly useful in workplaces, schools, and law enforcement settings where frequent, random testing is needed. As the technology improves, non-invasive methods are expected to become more reliable and widely accepted as part of routine substance abuse monitoring.
  • Mobile and Portable Testing Solutions: Mobile and portable testing solutions are transforming the POCT market by making drug testing more accessible and flexible. With the ability to test anywhere, these devices are particularly useful in remote or underserved areas where access to healthcare facilities is limited. Mobile testing units are also beneficial for law enforcement and workplace testing, providing rapid results in real-time. The development of smaller, more compact devices that are easy to use and carry is expanding the reach of POCT, ensuring that substance abuse monitoring can take place anytime and anywhere.

Emerging trends such as multiplex testing devices, digital health integration, at-home testing kits, non-invasive testing methods, and mobile solutions are transforming the POCT market for substance abuse. These trends enhance the accessibility, efficiency, and accuracy of testing, enabling better substance abuse management and recovery monitoring. As these trends continue to evolve, they will shape the future of drug testing, improving outcomes for individuals and communities worldwide.

Recent Developments in the Point-of-Care Testing (POCT) for Substance Abuse Market

Recent developments in the Point-of-Care Testing (POCT) for substance abuse market have been driven by technological advancements, the rise in substance abuse, and the need for more efficient testing solutions. These developments are transforming the landscape of drug testing in healthcare, workplaces, and law enforcement. Below are five key recent developments that are reshaping the market.

  • Introduction of Rapid, Multi-Drug Tests: Rapid, multi-drug tests have become a key development in the POCT market. These tests can detect various substances in a single sample, providing faster and more efficient results for healthcare providers, employers, and law enforcement agencies. By reducing the time and costs associated with running individual tests for each substance, multi-drug tests help streamline drug testing processes in a variety of settings. This development is essential for programs focused on monitoring patients with multiple substance use issues and for improving workplace safety.
  • Advances in Digital Integration for Real-Time Monitoring: Recent advances in digital technology have facilitated the integration of POCT devices with digital platforms for real-time monitoring and reporting. Healthcare providers and employers can now track drug test results instantly, ensuring quicker intervention and better management of substance abuse cases. This development is particularly beneficial in addiction treatment programs, where monitoring drug use over time is critical. It also enhances workplace drug testing programs by ensuring more accurate and timely decision-making.
  • Growth of Non-Invasive Testing Technologies: Non-invasive testing methods, such as saliva, sweat, and breath analysis, have made significant strides in the POCT market. These methods are less invasive and more convenient for patients, making them ideal for use in schools, workplaces, and healthcare settings. Non-invasive tests are also being adopted by law enforcement agencies for roadside drug testing, further expanding their use. As these technologies improve, they are expected to become more reliable and widely accepted, particularly in settings that require frequent or random testing.
  • Improved Accuracy and Sensitivity of Testing Devices: Recent advancements in POCT devices for substance abuse have focused on improving the accuracy and sensitivity of tests. This includes the development of more precise detection methods for low levels of substances in the body, such as fentanyl, which is becoming a significant concern in the opioid epidemic. By increasing the reliability of testing, these innovations help reduce false positives and negatives, ensuring that results are accurate and trustworthy. Improved accuracy is crucial for addiction treatment and workplace drug testing, as well as for monitoring law enforcement situations.
  • Regulatory Support for Expedited Approvals of Testing Devices: Regulatory bodies are providing more support for the expedited approval of POCT devices for substance abuse. This has led to the quicker availability of new and improved testing solutions in the market. For example, devices capable of detecting multiple drugs simultaneously have received faster regulatory approval, ensuring that healthcare providers, employers, and law enforcement agencies can access the tools they need to address the growing issue of substance abuse. This regulatory shift is driving innovation in the POCT market.

Recent developments in the POCT market for substance abuse, including multi-drug tests, digital integration, non-invasive testing, improved accuracy, and regulatory support, are revolutionizing the drug testing landscape. These advancements are improving the speed, accuracy, and accessibility of testing, which is essential for better substance abuse management across healthcare, workplace, and law enforcement settings. As these developments continue, they will play a significant role in combating the growing substance abuse epidemic.

Strategic Growth Opportunities in the Point-of-Care Testing (POCT) for Substance Abuse Market

The Point-of-Care Testing (POCT) for substance abuse market is expanding rapidly as more sectors look for efficient, accessible drug testing solutions. Key applications such as clinical diagnostics, workplace testing, and rehabilitation programs are creating growth opportunities for manufacturers. Here are five strategic growth opportunities within the POCT market for substance abuse.

  • Clinical Diagnostics in Addiction Treatment: Clinical diagnostics in addiction treatment is a major growth opportunity for POCT. Rapid testing for drugs allows healthcare providers to quickly assess patient conditions and monitor treatment progress. With more addiction treatment centers adopting POCT to track drug use and recovery, this sector is expected to continue growing. The ability to test patients frequently for a range of substances also helps in preventing relapse and ensuring patients receive appropriate care.
  • Workplace Testing for Drug Safety: Workplace drug testing is another key growth opportunity in the POCT market for substance abuse. Employers are increasingly adopting rapid drug testing solutions to ensure a safe and drug-free workplace. POCT devices that provide fast, reliable results are becoming essential for pre-employment screenings, random testing, and post-incident testing. The growing focus on workplace safety and productivity is driving the demand for these testing solutions.
  • At-Home Drug Testing Kits for Treatment Monitoring: At-home drug testing kits for individuals undergoing treatment or recovery programs represent an emerging growth opportunity. These kits offer convenience and privacy, enabling patients to monitor their substance use at home. As drug addiction continues to be a major public health issue, offering patients affordable and accessible home testing solutions will help them stay engaged in their recovery and reduce relapse rates.
  • Mobile Testing Units for Remote Areas: Mobile testing units for remote and underserved areas present a significant growth opportunity. These units allow for rapid testing in areas with limited access to healthcare facilities, improving drug abuse monitoring in rural areas. Mobile units are also helpful for law enforcement agencies and large employers who need on-site testing solutions. Expanding the reach of testing services into remote locations is critical for addressing the widespread nature of substance abuse.
  • Telemedicine Integration for Remote Monitoring: Telemedicine integration for remote monitoring of substance abuse is gaining traction as a growth opportunity. By combining POCT devices with telemedicine platforms, healthcare providers can remotely monitor patients and receive instant test results. This offers a more flexible and accessible approach to managing substance use disorders, particularly for patients in rural or underserved regions. This integration allows for real-time interventions and personalized treatment plans, improving patient outcomes.

Strategic growth opportunities in the POCT market for substance abuse lie in clinical diagnostics, workplace testing, at-home drug testing, mobile units, and telemedicine integration. These applications enhance the accessibility, efficiency, and affordability of drug testing, allowing for more effective substance abuse management across healthcare, workplaces, and remote areas. By focusing on these opportunities, manufacturers can help meet the growing demand for rapid, accurate drug testing solutions.

Point-of-Care Testing (POCT) for Substance Abuse Market Driver and Challenges

The Point-of-Care Testing (POCT) for substance abuse market is influenced by various drivers and challenges that impact its growth. Technological innovations, the rising prevalence of substance abuse, and regulatory support are driving the market, while economic, regulatory, and technical challenges continue to pose obstacles. Understanding these factors is crucial for companies looking to succeed in this evolving market.

The factors responsible for driving the point-of-care testing (POCT) for substance abuse market include:

1. Technological Advancements: Technological innovations in POCT devices are a primary driver of market growth. Advances in multiplex testing, non-invasive testing methods, and integration with digital health platforms have increased the efficiency and accuracy of drug testing. These developments make POCT solutions more accessible, cost-effective, and reliable, driving adoption across healthcare, workplaces, and law enforcement settings. As technology continues to evolve, it is expected to further enhance the capabilities of POCT devices, expanding their applications and improving outcomes.

2. Rising Substance Abuse: The increasing prevalence of substance abuse, particularly opioids, is a major driver of the POCT market. As addiction rates continue to rise, the demand for fast and accurate drug testing solutions grows. POCT enables healthcare providers and law enforcement agencies to respond more quickly to substance use and intervene early. The opioid epidemic, in particular, has highlighted the need for rapid testing to detect drug abuse and prevent overdose deaths, making POCT solutions essential for public health efforts.

3. Workplace Safety and Compliance: Workplace safety regulations are driving the demand for POCT solutions. Employers are increasingly adopting drug testing to ensure a safe and productive work environment. Rapid, accurate testing allows employers to meet compliance requirements and manage risks related to substance abuse in the workplace. As more companies prioritize drug-free environments, the demand for POCT devices in this sector is expected to grow, particularly in industries with safety-sensitive roles.

4. Regulatory Support: Governments and regulatory bodies are providing support for the development and approval of POCT devices for substance abuse. Faster regulatory approvals and more streamlined processes are helping companies bring new products to market more quickly. This regulatory environment encourages innovation and investment in POCT technology, making it easier for manufacturers to develop and introduce advanced solutions. Regulatory support also helps establish standards for testing accuracy and reliability, ensuring consistent quality across the market.

5. Patient-Centric Healthcare Approach: The shift towards a more patient-centric healthcare approach, where patients take an active role in managing their health, is driving demand for at-home drug testing solutions. Patients with substance use disorders benefit from the ability to monitor their drug use and stay engaged in their recovery process. POCT devices that enable self-testing are becoming increasingly popular, especially in addiction treatment programs that prioritize patient autonomy and continuous care.

Challenges in the point-of-care testing (POCT) for substance abuse market are:

1. Regulatory Hurdles: Regulatory challenges remain a significant barrier to the growth of the POCT market for substance abuse. Different countries have varying regulations and approval processes for POCT devices, which can delay the introduction of new products. Manufacturers must navigate complex regulatory requirements to ensure compliance, which can increase development costs and time to market. These hurdles can be particularly challenging for smaller companies with limited resources.

2. High Development Costs: The development and production of POCT devices for substance abuse can be costly, particularly for advanced testing technologies that require specialized materials and components. High development costs can result in higher prices for end users, limiting access to testing solutions in low-income regions. Manufacturers must find ways to reduce production costs without compromising the quality and accuracy of the tests to ensure affordability and wider adoption.

3. Accuracy and Reliability Concerns: While POCT devices have made significant advancements, there are still concerns regarding the accuracy and reliability of certain tests. False positives or false negatives can undermine the effectiveness of POCT, leading to misdiagnosis or mismanagement of substance abuse. Manufacturers must continue to improve the precision of their testing devices and ensure that they meet rigorous performance standards to gain widespread acceptance in healthcare, workplace, and law enforcement settings.

The major drivers of the POCT market for substance abuse include technological advancements, rising substance abuse, workplace safety concerns, regulatory support, and a patient-centric healthcare approach. However, challenges such as regulatory hurdles, high development costs, and accuracy concerns still need to be addressed. By overcoming these obstacles, the POCT market for substance abuse can continue to grow and provide essential tools for addressing the global substance abuse crisis.

List of Point-of-Care Testing (POCT) Companies for Substance Abuse Market

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies point-of-care testing (POCT) companies for substance abuse market cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the point-of-care testing (POCT) companies for substance abuse market are profiled in this report include-

  • Roche
  • Danaher
  • Abbott
  • Siemens
  • Beijing Hotgen Biotech
  • Hangzhou Biotest Biotech Co.
  • Assure Tech
  • Orient Gene
  • Thermo Fisher

Point-of-Care Testing (POCT) for Substance Abuse Market by Segment

The study includes a forecast for the global point-of-care testing (POCT) for substance abuse market by type, application, and region.

Point-of-Care Testing (POCT) for Substance Abuse Market by Type [Value from 2019 to 2031]:

  • Based on Colloidal Gold
  • Based on Fluorescence Immunochromatography

Point-of-Care Testing (POCT) for Substance Abuse Market by Application [Value from 2019 to 2031]:

  • Hospital
  • Diagnostic Center
  • Rehabilitation Centers
  • Workplace Testing Facilities
  • Home Testing Kits

Point-of-Care Testing (POCT) for Substance Abuse Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Point-of-Care Testing (POCT) for Substance Abuse Market

The Point-of-Care Testing (POCT) for substance abuse market is growing rapidly due to the increasing need for fast, accessible, and accurate drug testing solutions. POCT allows for the immediate detection of substances like opioids, cocaine, marijuana, and alcohol in various settings such as healthcare facilities, workplaces, and law enforcement. With the rise of substance abuse, especially opioid-related issues, countries like the United States, China, Germany, India, and Japan are increasingly adopting these technologies. In these countries, POCT is becoming a crucial tool for addressing addiction, ensuring workplace safety, and monitoring patients' substance use, reflecting key advancements in testing technologies.

  • United States: In the United States, the POCT market for substance abuse has expanded significantly due to the growing opioid crisis and a rising need for rapid drug testing in healthcare and workplace environments. Recent developments include more advanced urine, saliva, and hair follicle tests for a broader range of substances. There has been a push towards integrating digital solutions with POCT devices to streamline reporting and monitoring. Furthermore, the FDA has approved new POCT devices capable of detecting multiple drugs simultaneously, improving efficiency and accessibility. These developments are aimed at enhancing patient care and helping with drug monitoring programs.
  • China: The Chinese POCT market for substance abuse is also expanding as part of a broader effort to combat drug-related issues. The country has witnessed a rise in POCT devices capable of detecting substances like methamphetamine, heroin, and opiates, which is especially relevant as the government works to control the abuse of illegal drugs. Local manufacturers are developing affordable and accessible testing solutions tailored to meet the needs of public health systems, police forces, and businesses. China is also increasing its focus on integrating POCT technology into routine healthcare, contributing to better monitoring of individuals undergoing rehabilitation for drug addiction.
  • Germany: Germany has seen notable advancements in the POCT market for substance abuse due to stricter regulations and a growing awareness of addiction issues. Germany's healthcare system is increasingly adopting POCT for detecting drugs in patients with addiction disorders and in workplace environments. Recently, the development of more accurate and sensitive testing devices for opioids and other common illicit drugs has been a key trend. There is also a push towards better integration with digital health platforms to improve the monitoring of treatment adherence and drug rehabilitation outcomes. These developments are driving the adoption of POCT technology across public health and law enforcement sectors.
  • India: In India, the POCT market for substance abuse is emerging due to the increasing need for rapid drug testing in various sectors, including healthcare, law enforcement, and the workplace. Recent developments include the introduction of affordable and portable drug testing kits that are especially beneficial in rural areas with limited access to traditional laboratory facilities. India's push to address rising substance abuse and addiction problems has led to government initiatives supporting the use of POCT devices in public health campaigns. These efforts are also coupled with the growth of telemedicine, facilitating remote testing and consultation, which enhances accessibility for patients in remote areas.
  • Japan: Japan is witnessing growth in the POCT market for substance abuse, driven by rising concerns about drug use among the younger population. Recent advancements include the development of highly accurate tests for a wide range of substances, including amphetamines, narcotics, and cannabis. Japan's regulatory framework supports the use of POCT in workplaces and law enforcement, with a focus on non-invasive testing methods like saliva and sweat testing. Additionally, innovations in mobile testing units and the integration of POCT with digital health platforms for real-time monitoring are further accelerating the adoption of substance abuse testing solutions in the country.

Features of the Global Point-of-Care Testing (POCT) for Substance Abuse Market

  • Market Size Estimates: Point-of-care testing (POCT) for substance abuse market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Point-of-care testing (POCT) for substance abuse market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Point-of-care testing (POCT) for substance abuse market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the point-of-care testing (POCT) for substance abuse market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the point-of-care testing (POCT) for substance abuse market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the point-of-care testing (POCT) for substance abuse market by type (based on colloidal gold and based on fluorescence immunochromatography), application (hospital, diagnostic center, rehabilitation centers, workplace testing facilities, and home testing kits), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.1 Macroeconomic Trends and Forecasts
  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Point-of-Care Testing (POCT) for Substance Abuse Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Based on Colloidal Gold: Trends and Forecast (2019-2031)
  • 4.4 Based on Fluorescence Immunochromatography: Trends and Forecast (2019-2031)

5. Global Point-of-Care Testing (POCT) for Substance Abuse Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital: Trends and Forecast (2019-2031)
  • 5.4 Diagnostic Center: Trends and Forecast (2019-2031)
  • 5.5 Rehabilitation Centers: Trends and Forecast (2019-2031)
  • 5.6 Workplace Testing Facilities: Trends and Forecast (2019-2031)
  • 5.7 Home Testing Kits: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Point-of-Care Testing (POCT) for Substance Abuse Market by Region

7. North American Point-of-Care Testing (POCT) for Substance Abuse Market

  • 7.1 Overview
  • 7.2 North American Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • 7.3 North American Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • 7.4 United States Point-of-Care Testing (POCT) for Substance Abuse Market
  • 7.5 Mexican Point-of-Care Testing (POCT) for Substance Abuse Market
  • 7.6 Canadian Point-of-Care Testing (POCT) for Substance Abuse Market

8. European Point-of-Care Testing (POCT) for Substance Abuse Market

  • 8.1 Overview
  • 8.2 European Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • 8.3 European Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • 8.4 German Point-of-Care Testing (POCT) for Substance Abuse Market
  • 8.5 French Point-of-Care Testing (POCT) for Substance Abuse Market
  • 8.6 Spanish Point-of-Care Testing (POCT) for Substance Abuse Market
  • 8.7 Italian Point-of-Care Testing (POCT) for Substance Abuse Market
  • 8.8 United Kingdom Point-of-Care Testing (POCT) for Substance Abuse Market

9. APAC Point-of-Care Testing (POCT) for Substance Abuse Market

  • 9.1 Overview
  • 9.2 APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • 9.3 APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • 9.4 Japanese Point-of-Care Testing (POCT) for Substance Abuse Market
  • 9.5 Indian Point-of-Care Testing (POCT) for Substance Abuse Market
  • 9.6 Chinese Point-of-Care Testing (POCT) for Substance Abuse Market
  • 9.7 South Korean Point-of-Care Testing (POCT) for Substance Abuse Market
  • 9.8 Indonesian Point-of-Care Testing (POCT) for Substance Abuse Market

10. ROW Point-of-Care Testing (POCT) for Substance Abuse Market

  • 10.1 Overview
  • 10.2 ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • 10.3 ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • 10.4 Middle Eastern Point-of-Care Testing (POCT) for Substance Abuse Market
  • 10.5 South American Point-of-Care Testing (POCT) for Substance Abuse Market
  • 10.6 African Point-of-Care Testing (POCT) for Substance Abuse Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Roche
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Danaher
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Abbott
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Siemens
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Beijing Hotgen Biotech
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.7 Hangzhou Biotest Biotech Co.
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.8 Assure Tech
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.9 Orient Gene
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.10 Thermo Fisher
    • Company Overview
    • Point-of-Care Testing (POCT) for Substance Abuse Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 2.1: Usage of Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 2.2: Classification of the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 2.3: Supply Chain of the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 3.1: Trends of the Global GDP Growth Rate
  • Figure 3.2: Trends of the Global Population Growth Rate
  • Figure 3.3: Trends of the Global Inflation Rate
  • Figure 3.4: Trends of the Global Unemployment Rate
  • Figure 3.5: Trends of the Regional GDP Growth Rate
  • Figure 3.6: Trends of the Regional Population Growth Rate
  • Figure 3.7: Trends of the Regional Inflation Rate
  • Figure 3.8: Trends of the Regional Unemployment Rate
  • Figure 3.9: Trends of Regional Per Capita Income
  • Figure 3.10: Forecast for the Global GDP Growth Rate
  • Figure 3.11: Forecast for the Global Population Growth Rate
  • Figure 3.12: Forecast for the Global Inflation Rate
  • Figure 3.13: Forecast for the Global Unemployment Rate
  • Figure 3.14: Forecast for the Regional GDP Growth Rate
  • Figure 3.15: Forecast for the Regional Population Growth Rate
  • Figure 3.16: Forecast for the Regional Inflation Rate
  • Figure 3.17: Forecast for the Regional Unemployment Rate
  • Figure 3.18: Forecast for Regional Per Capita Income
  • Figure 3.19: Driver and Challenges of the Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 4.1: Global Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type
  • Figure 4.3: Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Based on Colloidal Gold in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Based on Fluorescence Immunochromatography in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.1: Global Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application
  • Figure 5.3: Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Diagnostic Center in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Rehabilitation Centers in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.7: Trends and Forecast for Workplace Testing Facilities in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 5.8: Trends and Forecast for Home Testing Kits in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 6.1: Trends of the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Region (2025-2031)
  • Figure 7.1: Trends and Forecast for the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 7.2: North American Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 7.3: Trends of the North American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2019-2024)
  • Figure 7.4: Forecast for the North American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2025-2031)
  • Figure 7.5: North American Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 7.6: Trends of the North American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2019-2024)
  • Figure 7.7: Forecast for the North American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2025-2031)
  • Figure 7.8: Trends and Forecast for the United States Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Mexican Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 7.10: Trends and Forecast for the Canadian Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.1: Trends and Forecast for the European Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 8.2: European Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 8.3: Trends of the European Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2019-2024)
  • Figure 8.4: Forecast for the European Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2025-2031)
  • Figure 8.5: European Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 8.6: Trends of the European Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2019-2024)
  • Figure 8.7: Forecast for the European Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2025-2031)
  • Figure 8.8: Trends and Forecast for the German Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the French Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Spanish Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the Italian Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 8.12: Trends and Forecast for the United Kingdom Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.1: Trends and Forecast for the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 9.2: APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 9.3: Trends of the APAC Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2019-2024)
  • Figure 9.4: Forecast for the APAC Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2025-2031)
  • Figure 9.5: APAC Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 9.6: Trends of the APAC Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2019-2024)
  • Figure 9.7: Forecast for the APAC Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2025-2031)
  • Figure 9.8: Trends and Forecast for the Japanese Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Indian Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Chinese Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the South Korean Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 9.12: Trends and Forecast for the Indonesian Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 10.1: Trends and Forecast for the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Figure 10.2: ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Type in 2019, 2024, and 2031
  • Figure 10.3: Trends of the ROW Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2019-2024)
  • Figure 10.4: Forecast for the ROW Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Type (2025-2031)
  • Figure 10.5: ROW Point-of-Care Testing (POCT) for Substance Abuse Market by Application in 2019, 2024, and 2031
  • Figure 10.6: Trends of the ROW Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2019-2024)
  • Figure 10.7: Forecast for the ROW Point-of-Care Testing (POCT) for Substance Abuse Market ($B) by Application (2025-2031)
  • Figure 10.8: Trends and Forecast for the Middle Eastern Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the South American Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the African Point-of-Care Testing (POCT) for Substance Abuse Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Point-of-Care Testing (POCT) for Substance Abuse Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • Figure 12.2: Growth Opportunities for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • Figure 12.3: Growth Opportunities for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Region
  • Figure 12.4: Emerging Trends in the Global Point-of-Care Testing (POCT) for Substance Abuse Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Point-of-Care Testing (POCT) for Substance Abuse Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Point-of-Care Testing (POCT) for Substance Abuse Market by Region
  • Table 1.3: Global Point-of-Care Testing (POCT) for Substance Abuse Market Parameters and Attributes
  • Table 3.1: Trends of the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 3.2: Forecast for the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 4.4: Trends of Based on Colloidal Gold in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 4.5: Forecast for Based on Colloidal Gold in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 4.6: Trends of Based on Fluorescence Immunochromatography in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 4.7: Forecast for Based on Fluorescence Immunochromatography in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Point-of-Care Testing (POCT) for Substance Abuse Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.4: Trends of Hospital in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.5: Forecast for Hospital in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.6: Trends of Diagnostic Center in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.7: Forecast for Diagnostic Center in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.8: Trends of Rehabilitation Centers in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.9: Forecast for Rehabilitation Centers in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.10: Trends of Workplace Testing Facilities in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.11: Forecast for Workplace Testing Facilities in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 5.12: Trends of Home Testing Kits in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 5.13: Forecast for Home Testing Kits in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 7.1: Trends of the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 7.2: Forecast for the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.1: Trends of the European Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 8.2: Forecast for the European Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.1: Trends of the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 9.2: Forecast for the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 10.1: Trends of the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 10.2: Forecast for the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Point-of-Care Testing (POCT) for Substance Abuse Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Point-of-Care Testing (POCT) for Substance Abuse Market (2019-2031)
  • Table 11.1: Product Mapping of Point-of-Care Testing (POCT) for Substance Abuse Suppliers Based on Segments
  • Table 11.2: Operational Integration of Point-of-Care Testing (POCT) for Substance Abuse Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Point-of-Care Testing (POCT) for Substance Abuse Revenue
  • Table 12.1: New Product Launches by Major Point-of-Care Testing (POCT) for Substance Abuse Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Point-of-Care Testing (POCT) for Substance Abuse Market